On November 24, 2021 Nuvo Pharmaceuticals Inc. (TSX:MRV; OTCQX:MRVFF) d/b/a Miravo Healthcare (Miravo or the Company), a Canadian focused healthcare company with global reach and a diversified portfolio of commercial products, reported that it will be presenting at the SNN Network Canada Virtual Event 2021 on Wednesday, December 8, 2021 at 11:00 a.m. ET (Press release, Nuvo Pharmaceuticals, NOV 24, 2021, View Source [SID1234596032]). Jesse Ledger, President & Chief Executive Officer and Mary-Jane Burkett, Vice President & Chief Financial Officer of Miravo will be hosting the presentation and answering questions from investors.
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
To access the live presentation, please use the following information:
SNN Network Canada Virtual Event 2021
Date: Wednesday, December 8, 2021
Time: 11:00 a.m. Eastern Time (8:00 a.m. Pacific Time)
Webcast: View Source
If you would like to book 1on1 investor meetings with Miravo Healthcare, and to watch Miravo Healthcare’s presentation, please make sure you are registered for the virtual event here: View Source
1on1 meetings will be scheduled and conducted via private, secure video conference through the conference event platform.
The SNN Network Canada Virtual Event website is available here: View Source
If you can’t make the live presentation, all company presentations "webcasts" will be available directly on the conference event platform on this link under the tab "Agenda": View Source